PARC Activators
The chemical class of PARC activators encompasses a range of compounds that can indirectly influence the activity of PARC (Cullin-9) through their effects on protein degradation pathways, cellular stress responses, and ubiquitination processes. These activators demonstrate the complex interplay between proteostasis mechanisms and the regulation of proteins involved in ubiquitination and proteasomal degradation. Proteasome inhibitors like MG132, bortezomib, and lactacystin are key in this class, as they modulate the ubiquitin-proteasome system, thereby potentially affecting PARC's role in ubiquitin-mediated protein turnover. The alteration of proteasomal function by these inhibitors underscores the importance of controlled protein degradation in cellular homeostasis and the potential indirect modulation of ubiquitin ligases like PARC.
Compounds that influence cellular stress responses, such as tunicamycin, chloroquine, and 17-AAG, also play a significant role. Tunicamycin, by inducing endoplasmic reticulum stress, and chloroquine and 17-AAG, through their impact on autophagy and chaperone-mediated protein folding, respectively, can indirectly modulate PARC activity. The connection between stress responses, protein folding, and degradation highlights the intricate balance of cellular proteostasis and its impact on proteins like PARC.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $204.00 | 1 | |
A calpain inhibitor that also affects proteasomal degradation, potentially influencing PARC activity by altering protein turnover. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Induces endoplasmic reticulum stress, potentially affecting PARC activity indirectly through the unfolded protein response and related ubiquitination processes. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
A HSP90 inhibitor, 17-AAG can affect protein folding and degradation, potentially influencing PARC activity through chaperone-mediated protein turnover. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Exhibits various cellular effects, including modulation of proteasomal and autophagic pathways, potentially affecting PARC activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor, sodium butyrate can influence gene expression and protein acetylation, potentially affecting PARC activity through epigenetic and post-translational modifications. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor and autophagy inducer, rapamycin can influence PARC activity indirectly by modulating autophagic and proteasomal degradation pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences various signaling pathways, including those related to proteostasis, potentially affecting PARC activity through its impact on protein degradation mechanisms. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Another HSP90 inhibitor, geldanamycin can indirectly affect PARC activity by influencing chaperone-mediated protein folding and degradation. | ||||||